|
| N | % | |
| Sex | Male | 23 | 65.7 |
| Female | 12 | 34.3 | |
| Clinical presentation | Visual | 29 | 82.9 |
| Headache | 21 | 60.0 | |
| Panhyporitutrism | 6 | 17.1 | |
| CN deficit | 2 | 5.7 | |
| Tumor size | Macro adenomas | 26 | 74.3 |
| Giant adenoma | 9 | 25.7 | |
| Visual outcome | Stable | 4 | 11.4 |
| Improve | 23 | 65.7 | |
| Worse | 2 | 5.7 | |
| Post-operative endocrine disorders | Temporary (DI) | 4 | 11.4 |
| Permanent (DI) | 0 | 0 | |
| Hypopituitarism | 6 | 17.1 | |
| Hematoma (Tumor bed) | 2 | 5.7 | |
| C.S.F leak | 5 | 14.3 | |
| Pneumocephalaus | 3 | 8.5 | |
| Recurrence/regrowth | 11 | 31.4 | |
| Extent of resection | GTR | 27 | 77.1 |
| STR | 8 | 22.9 | |